Autolus Therapeutics (AUTL)

• Market cap: $460M
• 1 day: 3.59%
• 5 days: 22.7%
• 1 month: 18.49%
• 3 months: 39.52%
• 6 months: 8.12%
• Year to date: -7.49%
• 1 year: -7.98%
• 5 years: -73.63%
• 10 years: -93.08%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647